ストックスクリーナーアプリを入手
76.59
0.31%
0.34
Ani Pharmaceuticals Inc (ANIP) 最新ニュース
Aug Wrap: Will ANI Pharmaceuticals Inc stock go up in YEARMarket Trend Summary & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
Is ANI Pharmaceuticals (ANIP) Pricing Reflect Long Term Value After Strong Multi Year Returns - Yahoo Finance
Thrivent Financial for Lutherans Has $5.32 Million Stake in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
Ranger Investment Management L.P. Decreases Stock Position in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
Is ANI Pharmaceuticals (ANIP) a Great Value Stock Right Now? - Yahoo Finance
Is ANI Pharmaceuticals (ANIP) Pricing Reflect Long Term Cash Flow Potential? - Sahm
ANI Pharmaceuticals Pivots to High-Value Rare Disease Treatments - AD HOC NEWS
ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: A Promising 37.97% Upside Awaits Investors - DirectorsTalk Interviews
ANI Pharmaceuticals, Inc. $ANIP is Lisanti Capital Growth LLC's 5th Largest Position - MarketBeat
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Did 53.60% Revenue Growth and Portfolio Expansion Just Shift ANI Pharmaceuticals' (ANIP) Investment Narrative? - Sahm
Trading Action: Is ANI Pharmaceuticals Inc exposed to political riskJuly 2025 Gainers & Reliable Volume Spike Alerts - baoquankhu1.vn
ANI Pharmaceuticals (ANIP) Stock Analysis: Exploring A 35.71% Potential Upside - DirectorsTalk Interviews
Implied Volatility Surging for ANI Pharmaceuticals Stock Options - Yahoo Finance
ANI Pharmaceuticals (NASDAQ:ANIP) Stock Passes Below Fifty Day Moving AverageHere's What Happened - MarketBeat
Investors Don't See Light At End Of ANI Pharmaceuticals, Inc.'s (NASDAQ:ANIP) Tunnel - 富途牛牛
40 Under 40: Kevin Chan, ANI Pharmaceuticals - Medical Marketing and Media
ANI Pharmaceuticals, Inc. (ANIP): Investor Outlook With A Promising 30% Upside Potential - DirectorsTalk Interviews
Breakout Move: Does ANI Pharmaceuticals Inc stock have upside surprise potential - baoquankhu1.vn
ANI Pharmaceuticals, Inc. $ANIP Shares Sold by Mizuho Markets Americas LLC - MarketBeat
Aug Setups: What is the next catalyst for SEALPRAQuarterly Earnings Report & Technical Pattern Based Signals - baoquankhu1.vn
Campbell & CO Investment Adviser LLC Invests $1.60 Million in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
ANI Pharmaceuticals (ANIP) Is Up 11.2% After Raising 2026 Revenue Outlook And Rare Disease Hiring Plan – Has The Bull Case Changed? - Sahm
Is ANI Pharmaceuticals (ANIP) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
ANIP vs. TEVA: Which Drug Stock Is the Better Buy Right Now? - Eastern Progress
ANIP Stock Rises 7% in a Week: Here's What You Should Know - Eastern Progress
Guggenheim Reaffirms Their Buy Rating on ANI Pharmaceuticals (ANIP) - The Globe and Mail
SG Americas Securities LLC Boosts Stock Position in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
ANI Pharmaceuticals (ANIP) Is Up 7.0% After Raising 2026 Revenue Outlook and Expanding Rare Disease Team - Yahoo Finance
Insider Sell Alert: Meredith Cook Sells Shares of ANI Pharmaceuticals Inc (ANIP) - GuruFocus
Ani Pharmaceuticals’ Cook sells $42,165 in stock By Investing.com - Investing.com Australia
Insider Selling: ANI Pharmaceuticals (NASDAQ:ANIP) VP Sells 500 Shares of Stock - MarketBeat
Ani Pharmaceuticals’ Cook sells $42,165 in stock - Investing.com
ANI Pharmaceuticals Targets $1B+ 2026 Revenue as Rare Disease Pivot Accelerates, Cortrophin Leads Growth - Yahoo Finance
ANI Pharmaceuticals (ANIP) Stock Dips on Profit-Taking After 2026 GuidanceNews and Statistics - IndexBox
ANI Pharmaceuticals (ANIP) Stock Trades Down, Here Is Why - Finviz
Dow Theory LettersANI Pharmaceuticals (ANIP) Stock Trades Down, Here Is Why - FinancialContent
ANI Pharmaceuticals: Strong 2025 Finish And Bullish 2026 Guidance (NASDAQ:ANIP) - Seeking Alpha
Stocks making big moves yesterday: OneMain, Nextpower, ANI Pharmaceuticals, Akamai Technologies, and Lemonade - The Globe and Mail
Growth Review: Can ANI Pharmaceuticals Inc. stock deliver consistent earnings growth2025 Performance Recap & Stepwise Trade Signal Implementation - Bộ Nội Vụ
Fund Flows: Why ANI Pharmaceuticals Inc stock remains undervaluedEarnings Risk Summary & Low Risk Entry Point Guides - Bộ Nội Vụ
ANI Pharmaceuticals, Inc. (ANIP) Investor Outlook: Exploring a 29.52% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Decker Retirement Planning Inc. Boosts Position in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
ANI Pharmaceuticals expects over $1 billion in 2026 revenue By Investing.com - Investing.com Nigeria
Why ANI Pharmaceuticals (ANIP) Stock Is Trading Up Today - Finviz
The Sun: Local News, Sports and Things to DoWhy ANI Pharmaceuticals (ANIP) Stock Is Trading Up Today - FinancialContent
ANI Pharmaceuticals (NASDAQ:ANIP) Shares Gap UpTime to Buy? - MarketBeat
Ani Pharmaceuticals, Inc. Provides Revenue Guidance for the Full Year 2026 - marketscreener.com
ANI Pharmaceuticals (NASDAQ:ANIP) Updates FY 2025 Earnings Guidance - MarketBeat
ANI Pharmaceuticals Highlights Significant Growth in 2025, Provides 2026 Financial Guidance, and Outlines Strategic Priorities - The Manila Times
ANI Pharmaceuticals expects over $1 billion in 2026 revenue - Investing.com
ANI Pharma is building a 90-person rare disease team for gout flares in 2026 - Stock Titan
ANI Pharmaceuticals (ANIP) Valuation Check After Robust 2025 Results And Raised Guidance - Sahm
0.80%
10.39%
大文字化:
|
ボリューム (24 時間):